At the PTCOG-AO 2026 conference in Chennai, international experts discussed cost-effective protocols to make particle therapy more accessible to underserved communities. The event highlighted the intersection of advanced technology and radiation safety.

  • International experts met in Chennai to discuss making particle therapy more affordable.
  • The PTCOG-AO 2026 conference focused on expanding access to underserved populations.
  • AERB emphasized strengthened oversight and safety in radiation facilities.

In a significant move towards revolutionizing oncology, experts gathered at an international conference in Chennai to deliberate on improving access to particle therapy through cost-effective treatment protocols. The two-day Particle Therapy Cooperative Group – Asia Oceania 2026 (PTCOG-AO) conference, hosted by the Apollo Proton Cancer Centre, served as a global platform for presenting cutting-edge research and future directions in cancer treatment.

The conference was inaugurated by A.K. Balasubrahmanian, Chairperson of the Atomic Energy Regulatory Board (AERB), in the presence of distinguished leaders including Marco Durante (President, PTCOG), Tatsuya Ohno (President, PTCOG-AO), Preetha Reddy (Executive Vice-Chairperson, Apollo Hospitals), and Harshad Reddy (Director, Apollo Hospitals).

Advancing Safety and Precision

During his keynote address, Mr. Balasubrahmanian highlighted the pivotal role of advanced technology in making cancer care more precise, affordable, and accessible. He emphasized that technological leaps must be supported by rigorous research, specialized training, and a highly skilled workforce. Furthermore, he noted that the AERB has strengthened its oversight of nuclear and radiation facilities to ensure the highest safety standards and compliance with international protection principles.

Advanced technology, combined with robust research and skilled personnel, is the key to making cancer care precise and accessible.

In a video message, Prathap Reddy, Chairperson of Apollo Hospitals, underscored that the fight against cancer requires more than just scientific advancement; it demands global collaboration and the collective sharing of ideas across borders.

Why This Matters

BozokMedia analysis shows that while particle therapy offers superior precision compared to conventional radiation, its high cost remains a significant barrier. Democratizing this technology is essential to ensure that life-saving innovations are not restricted to the wealthy but are available to all socio-economic segments of society.

Preetha Reddy echoed this sentiment, stressing the urgent need to democratize access to medicine and ensure that healthcare advancements reach diverse communities across the globe.

Historical Background

Particle therapy, including proton beam therapy, represents a major leap in radiation oncology. Unlike traditional X-ray radiation, which passes through the body, particles can be programmed to release their maximum energy at a specific depth, minimizing damage to surrounding healthy tissues and organs.

Did You Know?: Particle therapy allows doctors to target tumors with extreme precision, significantly reducing side effects in pediatric cancer patients.

Frequently Asked Questions

Question 1: What is the main goal of the PTCOG-AO conference?
Answer: The conference aims to share research and discuss ways to make particle therapy more accessible and affordable globally.

Question 2: How does AERB contribute to cancer treatment safety?
Answer: AERB provides oversight and ensures that radiation facilities follow strict safety and protection protocols.